Liver Cancer Clinical Trials in Mesa, AZ

24 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Phase 3	ECOG-ACRIN Cancer Research Group	5 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	5 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen	Phase 3	Crinetics Pharmaceuticals Inc.	5 mi
CREO - Microwave Ablation Feasibility Study	N/A	Banner Health	5 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Phase 2	AstraZeneca	8 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)	Phase 1/2	GI Innovation, Inc.	8 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	8 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies	Phase 1	BioEclipse Therapeutics	8 mi
FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/2	Parabilis Medicines, Inc.	8 mi
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	Phase 2	Academic and Community Cancer Research United	8 mi
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years	Phase 4	Guerbet	8 mi
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment	Phase 1	Incyte Corporation	8 mi
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors	Phase 1/2	VM Discovery, Inc.	8 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	14 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	14 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor	Phase 1	Abbisko Therapeutics Co, Ltd	14 mi
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors	Phase 1	Exelixis	14 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	14 mi
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform	—	Mayo Clinic	14 mi
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer	Phase 1	TORL Biotherapeutics, LLC	14 mi
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC	Phase 1/2	RayzeBio, Inc.	14 mi
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)	N/A	Johns Hopkins University	14 mi
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors	Phase 1/2	BeOne Medicines	30 mi
DESTINY-PANTUMOUR04	—	AstraZeneca	37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.